Connect with us

Published

on

By Marzia Khan Reviewed by Danielle Ellis, B.Sc.

Mechanics of insulin pumps: Precision delivery for blood sugar control
Understanding basal rates and bolus doses
Clinical and lifestyle benefits of insulin pump therapy
Key factors in choosing and using an insulin pump
Advances shaping the future of insulin pump technology
References
Further reading

With the prevalence of diabetes quadrupling in recent decades and currently impacting more than 500 million people in the world, it is no surprise that the technology for insulin delivery has also evolved.1,2

An insulin pump is a cell phone-sized wearable device that carries a reservoir of insulin for the user. This device is programmed to dispense specific volumes of insulin automatically when consuming food.3

While the first commercial insulin pump reached the market in the 1970s, its rapid uptake by users only occurred from the early 2000s, with the Diabetes Control and Complication Trial (DCCT) in the early 1990s demonstrating the significance of intensive insulin therapy for optimum glycemic control and avoid complications related to diabetes.4

Since its uptake, insulin pumps have been shown to be an innovative alternative to multiple daily insulin injections for those with diabetes who require insulin to manage their condition.5

Additionally, users of insulin pumps have their basal insulin constantly delivered without worrying about remembering to inject their insulin, with the device having the capacity to be programmed to deliver a higher amount of insulin at particular times during the day or even during sleep.3 Mechanics of insulin pumps: Precision delivery for blood sugar control

There are three main components of insulin pumps: (i) the pump, (ii) the infusion set, and (iii) the sensor and transmitter in sensor-augmented insulin pumps.2 An insulin pump system featuring a continuous glucose sensor to monitor blood sugar levels, an infusion set to deliver insulin, and a pump device for precise diabetes management.

Most devices consist of a pump and infusion set that are separate from each other, with a connecting plastic tube; however, some devices combine both of these components without the requirement of a tube – this is known as a tubeless pump.2

Tubed insulin pumps utilize a long and thin tube that connects the pump to a cannula under the skin to deliver insulin to individuals. A tubed insulin pump is usually constructed with durable plastic and metal, with an interactive screen for viewing and modifying various settings. It also consists of a cartridge or reservoir of insulin with a replaceable or rechargeable battery.5

Most reservoirs require changing every two to three days or once the insulin runs out.2 Most components of the device, such as the reservoirs and tubing, are replaced, but the pump itself usually lasts for many years.5

However, tubeless insulin pumps, such as patch pumps, use a flexible plastic tube or cannula under the skin, with the insulin reservoir and cannula being part of one “pod” that sits on the skin with the aid of an adhesive patch. This category of devices does not utilize an external tube, and the pump is managed using a handheld wireless controller.5

This type of pump consists of the user filling the reservoir with insulin before attaching the pod and fixing the adhesive to the skin. A button is then pushed to release a needle that is threaded through the cannula in the pod, which is retracted back into the pod and remains under the skin.5 Understanding basal rates and bolus doses

Insulin pumps mimic the way the pancreas naturally releases insulin in two different ways.5

The first way is through basal insulin, consisting of small and continuous insulin doses. Most pumps deliver basal rates that the user and their healthcare provider manually program.5 This consists of the insulin being continuously delivered at a preset or auto-adjusted rate for a basal supply, which lasts for 24 hours.2,5

Basal rates require changing over time as the body and routines change, which would need adjustment with the help of a healthcare provider. All pumps can automatically adjust basal doses dependent on an individual’s glucose levels, which are monitored via a connected continuous glucose monitoring (CGM) program.5

Image Credit: News-Medical.net

Another way pumps work is through bolus doses, including manual increases of insulin when eating or to correct high blood sugar. Pumps utilize information entered about carbohydrate intake and blood sugar levels to calculate how much bolus insulin is required. A majority of pumps provide a recommended dose that a user can either confirm or adjust before delivering insulin.2,5,7 Clinical and lifestyle benefits of insulin pump therapy

Insulin pumps deliver continuous insulin with a flexible and precise approach to managing a diabetes diagnosis. There are many benefits of using an insulin pump compared to traditional management methods such as insulin injections.8 Related StoriesResearchers identify key mechanisms behind heart disease in type 2 diabetesFive servings of dark chocolate a week may protect against type 2 diabetesEating breakfast later lowers blood sugar spikes in type 2 diabetes patients

Insulin pumps offer improved glycemic control as the continuous delivery of insulin and precise adjustment enable users to have more stable blood glucose levels.4 Subsequently, this decreases the risk of hyperglycemia, also known as high blood sugar, as well as hypoglycemia or low blood sugar.8

Additionally, insulin pumps can also provide a higher level of flexibility and freedom in lifestyle choices, including meal timing, exercise, and travel, without the thought of having to inject insulin depending on the activity.4,8 However, with the use of injections, any changes to basal insulin require careful planning several hours in advance.6

Insulin pump users can easily adjust and modify insulin delivery for various activities, including spontaneous events, leading to an increased quality of life and a sense of control over their diabetes management.8 The Impact of Glucagon on Diabetes Management

A statistical study reported the most common insulin-related errors, which included missed doses of insulin (25%), timing errors (22.7%), and missed documentation of insulin doses (15.5%).1 With these in mind, the use of an automated insulin delivery system, such as through an insulin pump, may be more beneficial to mitigate the risks of missed doses.8

While an insulin pump can cost approximately $6000 in the United States, with the supplies costing between $3000 to $6000 yearly, patients who switch from multiple-dose insulin injections to pumps in a managed care setting have seen a reduced insulin expenditure by approximately $657 per year.9 Key factors in choosing and using an insulin pump

Many insulin pumps are integrated with continuous glucose monitoring (CGM), which continuously tracks glucose levels in real-time, enabling automated insulin adjustments and alerts and enhancing overall glucose management.8

However, while pumps are advanced devices, there are some drawbacks and considerations, such as the cost of insulin pumps and their supplies, which can be expensive and act as a barrier for many individuals unable to afford these devices.8

Additionally, there is also a need for ongoing education and support required for users of insulin pumps in order to be able to manage the device effectively. This can be a limitation for some who may find the technology to be overwhelming or complicated.8

Potential complications with insulin pumps also include technical issues and malfunctions, as with any electronic device, which requires users to be prepared to troubleshoot these issues and carry backup supplies and insulin.8

Regular pump site care is also required, as the infusion site can occasionally result in irritation, discomfort, or infection.8

Other complications of the pump also include the risk of diabetic ketoacidosis (DKA), as insulin pumps deliver rapid-acting insulin, and so if the pump fails or if there is an obstruction in delivering insulin, this can lead to DKA.8 Advances shaping the future of insulin pump technology

The transformation of glucose management methods has also expanded using artificial intelligence (AI), with this realm introducing innovative strategies. This evolution included transitioning from using pumps based on proportional integral derivative (PID) controllers to using a model based on a predictive control (MPC) approach. MPC utilizes dynamic models to predict future behavior and consider current control inputs.10

Personalized models are also evolving continuously to predict immediate blood glucose events as well as long-term glucose trends through the use of individual blood glucose data, with a high level of accuracy and a margin of error of 10%.10

With advancements in this area of medical devices, newer and more refined technologies aim to have better ease of use and quality of care, which leads to improved glycemic control.2 References Thota S. Insulin. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK560688/#:~:text=The%20insulin%20pump%20is%20a%20device%20that%20works,short-acting%20insulin%20to%20the%20body%20throughout%20the%20day. Published July 10, 2023. Accessed December 2, 2024. Yao PY. Insulin Pump. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK555961/. Published August 28, 2023. Accessed December 2, 2024. Insulin Pump. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/type-1-diabetes/multimedia/insulin-pump/img-20006962. Accessed November 25, 2024. Berget C, Messer LH, Forlenza GP. A clinical overview of insulin pump therapy for the management of diabetes: Past, present, and future of intensive therapy. Diabetes Spectrum. 2019;32(3):194-204. doi:10.2337/ds18-0091. https://pmc.ncbi.nlm.nih.gov/articles/PMC6695255/ Types of Insulin Pumps. Cleveland Clinic. https://my.clevelandclinic.org/health/articles/insulin-pumps. Published November 12, 2023. Accessed November 25, 2024. Singh A. Multiple Insulin Injections Vs Insulin Pumps. Diabetes. https://www.diabetes.co.uk/insulin/mdi-vs-insulin-pumps.html. Published October 29, 2023. Accessed November 25, 2024. Yeh T, Yeung M, Mendelsohn Curanaj FA. Managing patients with insulin pumps and continuous glucose monitors in the hospital: To wear or not to wear. Current Diabetes Reports. 2021;21(2). doi:10.1007/s11892-021-01375-7. https://pubmed.ncbi.nlm.nih.gov/33449214/ Lorenyz C. Insulin Pump Therapy for Glycemic Control: Benefits and Potential Drawbacks. Diabetes Management. 2024;14(4):642-643. doi:10.37532/1758-1907.2024.14(4).642-643. https://www.openaccessjournals.com/articles/insulin-pump-therapy-for-glycemic-control-benefits-and-potential-drawbacks.pdf McAdams B, Rizvi A. An overview of insulin pumps and glucose sensors for the generalist. Journal of Clinical Medicine. 2016;5(1):5. doi:10.3390/jcm5010005. https://pubmed.ncbi.nlm.nih.gov/26742082/ Yu TS, Song S, Yea J, Jang K. Diabetes management in transition: Market insights and technological advancements in CGM and insulin delivery. Advanced Sensor Research. 2024;3(10). doi:10.1002/adsr.202400048. https://onlinelibrary.wiley.com/doi/10.1002/adsr.202400048

 Further ReadingAll Diabetes ContentWhat is Diabetes?COVID-19 and DiabetesWhat Causes Diabetes?Diabetes PathophysiologyMore… 

Last Updated: Dec 11, 2024

Continue Reading

World

British couple killed in Lisbon funicular crash named

Published

on

By

British couple killed in Lisbon funicular crash named

Two of the three Britons killed in the Lisbon funicular crash have been named.

Kayleigh Smith, 36, and William Nelson, 44, were a couple and died alongside 14 others in Wednesday’s incident.

Ms Smith graduated from the Arden School of Theatre in Manchester, where Mr Nelson ran the master’s degree in directing.

Please use Chrome browser for a more accessible video player

Lisbon crash: What happened?

The identity of the third British victim has not yet been confirmed.

MADS theatre in Macclesfield, Cheshire, said Ms Smith was a “valued member of our society” who will be “greatly missed”.

It said she was an award-winning director and actress, who had also done multiple crew and front-of-house roles.

Five Portuguese citizens died when the packed carriage plummeted out of control – four of them workers at a charity on the hill – but most victims were foreigners.

Police said the other fatalities were two Canadians, two South Koreans, one American, one French citizen, one Swiss and one Ukrainian.

All but one were declared dead at the scene – and 21 others in the packed carriage were injured.

Please use Chrome browser for a more accessible video player

‘We felt no brakes anymore’

The yellow carriages of the Gloria funicular are a big draw for tourists, as well as a proud symbol of the Portuguese capital.

The journey is just 265m (870ft) up a steep hill and takes three minutes, with two carriages travelling in opposite directions on a linked cable.

Read more:
Everything we know about the Lisbon crash

Witnesses reported seeing one of the carriages hurtle down the hill before derailing and crashing 30m from the bottom.

The aftermath shows it crumpled and twisted against the side of a building.

People who were in the bottom carriage said they were a few metres into the climb when it started going backwards.

When they saw the other car speeding towards them, many jumped through the windows to escape.

The crash happened around 6pm on Wednesday. Pic: Reuters
Image:
The crash happened around 6pm on Wednesday. Pic: Reuters

Prime Minister Luis Montenegro called the crash “one of the biggest tragedies of our recent past” and authorities are under intense pressure to quickly identifying the cause.

One witness who was in the lower carriage told Sky’s Europe correspondent Alistair Bunkall that the brakes appeared to fail.

The carriage’s brakeman, Andre Marques, has also been confirmed among the dead.

Please use Chrome browser for a more accessible video player

‘I screamed, we’re all going to die’

Officials said the streetcar, which has been running since 1914, had a half-hour visual inspection every day and underwent full maintenance last year.

The line links the downtown area near Restauradores Square with Lisbon’s Bairro Alto neighbourhood.

A preliminary technical report due on Friday has now been delayed until Saturday. Another report with a broader scope is expected within 45 days.

Three other funicular lines in Lisbon have been suspended.

Continue Reading

US

475 people detained during immigration raid on Hyundai factory in Georgia

Published

on

By

475 people detained during immigration raid on Hyundai factory in Georgia

Officers detained 475 people during an immigration raid on a Hyundai factory for electric vehicles in Georgia.

The majority of those detained at the 3,000-acre site west of Savannah are from South Korea, according to Steven Schrank, special agent in charge at Homeland Security Investigations.

Mr Schrank said the raid was the “largest single-site enforcement operation” in the history of the agency and followed an investigation of several months, which involved leads from community members and former workers.

The spokesman for the South Korean foreign ministry, Lee Jaewoong, said there was a “large” number of South Koreans among those detained in the raid, but did not provide an exact number.

A 'large' number of those detained were from South Korea
Image:
A ‘large’ number of those detained were from South Korea

He said the detained workers were part of a “network of subcontractors” and that the employees worked for several different companies on the Georgia site.

Mr Lee said South Korea’s foreign ministry is dispatching diplomats from its embassy in Washington and consulate in Atlanta to the site, and plans to form an on-site response team centred on the local mission.

“The business activities of our investors and the rights of our nationals must not be unjustly infringed in the process of US law enforcement,” Mr Lee added.

More on Georgia, Us

The Department of Homeland Security said in a statement that agents executed a search warrant “as part of an ongoing criminal investigation into allegations of unlawful employment practices and other serious federal crimes”.

The manufacturing site, which employs about 1,200 people, has been hailed as the largest economic development project in the state’s history by Governor Brian Kemp and other officials.

The Hyundai Motor Group plant in Georgia. File pic: AP Photo/Mike Stewart
Image:
The Hyundai Motor Group plant in Georgia. File pic: AP Photo/Mike Stewart

Hyundai Motor Group, the biggest automaker in South Korea, started manufacturing electric vehicles at the $7.6bn (£7.4bn) site a year ago and partnered with LG Energy Solution to build an adjacent battery plant, which is set to open in 2026.

ICE spokesman Lindsay Williams confirmed the raid and said agents were focused on the construction site for the battery plant.

LG said in a statement that it was “closely monitoring the situation and gathered all relevant details”. The firm said it couldn’t immediately confirm how many of its employees or Hyundai workers had been detained.

“Our top priority is always ensuring the safety and well-being of our employees and partners. We will fully cooperate with the relevant authorities,” LG said.

Hyundai and LG’s battery joint venture, HL-GA Battery Company, said in a statement that it’s “cooperating fully with the appropriate authorities” and paused construction of the battery site to assist the investigation.

Operations at Hyundai’s electric vehicle manufacturing plant weren’t interrupted, plant spokesperson Biance Johnson said.

Read more from Sky News:
Trump to rebrand Pentagon as Department of War
Former President Biden has skin cancer surgery

The raid is the latest in a series of sweeping ICE operations as part of President Donald Trump’s mass deportation agenda, which saw immigration officers raid farms, construction sites, restaurants and auto repair shops.

The US labour force lost more than 1.2 million immigrants from January through July, which includes legal and illegal immigrants, according to the Pew Research Centre, citing preliminary census data.

Continue Reading

US

Joe Biden has skin cancer surgery – months after ‘aggressive’ prostate cancer diagnosis

Published

on

By

Joe Biden has skin cancer surgery - months after 'aggressive' prostate cancer diagnosis

Former US president Joe Biden has had surgery for skin cancer, his spokesperson has said.

It’s unclear when he had the procedure, but video from late August showed him leaving church in Delaware with a large, fresh scar on his head.

The spokesperson told Sky’s US partner, NBC News, that he was recovering well.

Mr Biden had Mohs surgery, which involves removing a layer of tissue, examining it under a microscope to see if any cancer cells remain, and repeating if necessary.

The 82-year had a basal cell carcinoma, one of the two most common skin cancer types, removed from his chest in 2023.

His doctor said at the time that all the cancerous cells had been removed.

The same year, Mr Biden’s wife, Jill, had two basal cell carcinomas removed from near her eye and on her chest.

The former president also revealed this May that he had stage-four prostate cancer – with the disease having spread to his bones and having a Gleason score of nine.

Such a score means the disease is “likely to grow quickly”, according to Cancer Research UK.

Follow the World
Follow the World

Listen to The World with Richard Engel and Yalda Hakim every Wednesday

Tap to follow

Read more from Sky News:
Trump to rebrand Pentagon as ‘Department of War’
The proxy war that will redefine US public health

His office said the prostate cancer was discovered when Mr Biden visited a doctor for urinary symptoms and that he was considering “multiple treatment options”.

“While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management,” said a statement.

Continue Reading

Trending